Filing Details
- Accession Number:
- 0000899243-19-021306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-07 21:01:13
- Reporting Period:
- 2019-08-05
- Accepted Time:
- 2019-08-07 21:01:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896262 | Amedisys Inc | AMED | Services-Home Health Care Services (8082) | 113131700 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1543701 | G Scott Ginn | 3854 American Way, Suite A Baton Rouge LA 70816 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-08-05 | 800 | $130.66 | 17,610 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-08-05 | 4,071 | $132.34 | 13,539 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,672 | Indirect | Through 401(k) Plan |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.36 to $131.30, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.845 to $132.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- The information in this report is based on a plan statement dated as of June 30, 2019.